DermaSensor Inc. is a fast-growing, Miami-based medical device company focused on empowering healthcare professionals with clinically proven solutions to efficiently detect skin cancer using the latest advancements in medical-grade technology. Our flagship product, the FDA-cleared DermaSensor™ medical device, is a cost-effective handheld solution that combines artificial intelligence and spectroscopy to assess suspicious skin lesions for skin cancer risk in just seconds. By enabling real-time, accurate assessments, DermaSensor aims to dramatically improve early detection rates, increase access to vital healthcare, and ultimately save lives. Join us as we reshape the future of healthcare with groundbreaking technology designed to make a lasting impact on patient care and outcomes.